Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002530523 | SCV000770780 | benign | Dyskeratosis congenita, autosomal dominant 2; Idiopathic Pulmonary Fibrosis | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001816617 | SCV002071681 | likely benign | not specified | 2019-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002248843 | SCV002520159 | likely benign | not provided | 2019-11-25 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Sema4, |
RCV002257903 | SCV002533123 | likely benign | Dyskeratosis congenita | 2021-06-17 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002257903 | SCV002731102 | likely benign | Dyskeratosis congenita | 2022-03-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004544888 | SCV004763853 | likely benign | TERT-related disorder | 2023-10-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |